ATE116650T1 - Sulfonylamin substituierte bizyklische hydroxansäurederivate. - Google Patents
Sulfonylamin substituierte bizyklische hydroxansäurederivate.Info
- Publication number
- ATE116650T1 ATE116650T1 AT91106218T AT91106218T ATE116650T1 AT E116650 T1 ATE116650 T1 AT E116650T1 AT 91106218 T AT91106218 T AT 91106218T AT 91106218 T AT91106218 T AT 91106218T AT E116650 T1 ATE116650 T1 AT E116650T1
- Authority
- AT
- Austria
- Prior art keywords
- acid derivatives
- substituted
- bizyclic
- sulfonylamine
- txa2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/10—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10372890 | 1990-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE116650T1 true ATE116650T1 (de) | 1995-01-15 |
Family
ID=14361715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91106218T ATE116650T1 (de) | 1990-04-19 | 1991-04-18 | Sulfonylamin substituierte bizyklische hydroxansäurederivate. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5137914A (de) |
EP (1) | EP0453960B1 (de) |
JP (1) | JP2984077B2 (de) |
KR (1) | KR970002488B1 (de) |
AT (1) | ATE116650T1 (de) |
CA (1) | CA2040319C (de) |
DE (1) | DE69106425T2 (de) |
DK (1) | DK0453960T3 (de) |
ES (1) | ES2069112T3 (de) |
GR (1) | GR3015475T3 (de) |
HU (1) | HU210687B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993012075A1 (en) * | 1991-12-10 | 1993-06-24 | Shionogi & Co., Ltd. | Hydroxamic acid derivative based on aromatic sulfonamide |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
PT950059E (pt) * | 1997-01-06 | 2004-10-29 | Pfizer | Derivados de sulfona ciclicos |
US5883131A (en) * | 1997-07-09 | 1999-03-16 | Pfizer Inc. | Cyclic sulfone derivatives |
US7914486B2 (en) | 2001-12-20 | 2011-03-29 | Boston Scientific Scimed, Inc. | Catheter having an improved balloon-to-catheter bond |
US6923787B2 (en) | 2001-12-20 | 2005-08-02 | Scimed Life Systems, Inc. | Catheter having an improved balloon-to-catheter bond |
US6727277B1 (en) | 2002-11-12 | 2004-04-27 | Kansas State University Research Foundation | Compounds affecting cholesterol absorption |
KR102375396B1 (ko) | 2014-05-13 | 2022-03-18 | 노파르티스 아게 | 연골형성을 유도하기 위한 화합물 및 조성물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4456616A (en) * | 1982-12-27 | 1984-06-26 | E. R. Squibb & Sons, Inc. | 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction |
US4663336A (en) * | 1985-07-01 | 1987-05-05 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease |
US4654357A (en) * | 1985-08-09 | 1987-03-31 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptane substituted sulfonamide prostaglandin analogs |
NZ218115A (en) * | 1985-11-18 | 1990-02-26 | Shionogi & Co | Bicyclic sulphonamides and pharmaceutical compositions |
-
1991
- 1991-03-05 JP JP3065483A patent/JP2984077B2/ja not_active Expired - Fee Related
- 1991-03-15 US US07/668,853 patent/US5137914A/en not_active Expired - Fee Related
- 1991-04-12 CA CA002040319A patent/CA2040319C/en not_active Expired - Fee Related
- 1991-04-18 DE DE69106425T patent/DE69106425T2/de not_active Expired - Fee Related
- 1991-04-18 DK DK91106218.0T patent/DK0453960T3/da active
- 1991-04-18 EP EP91106218A patent/EP0453960B1/de not_active Expired - Lifetime
- 1991-04-18 ES ES91106218T patent/ES2069112T3/es not_active Expired - Lifetime
- 1991-04-18 HU HU911277A patent/HU210687B/hu not_active IP Right Cessation
- 1991-04-18 AT AT91106218T patent/ATE116650T1/de not_active IP Right Cessation
- 1991-04-19 KR KR1019910006327A patent/KR970002488B1/ko not_active IP Right Cessation
-
1995
- 1995-03-20 GR GR950400606T patent/GR3015475T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR970002488B1 (ko) | 1997-03-05 |
JPH04211642A (ja) | 1992-08-03 |
DK0453960T3 (da) | 1995-03-13 |
ES2069112T3 (es) | 1995-05-01 |
KR910018348A (ko) | 1991-11-30 |
JP2984077B2 (ja) | 1999-11-29 |
HUT57716A (en) | 1991-12-30 |
HU911277D0 (en) | 1991-10-28 |
DE69106425T2 (de) | 1995-05-04 |
US5137914A (en) | 1992-08-11 |
EP0453960B1 (de) | 1995-01-04 |
CA2040319A1 (en) | 1991-10-20 |
GR3015475T3 (en) | 1995-06-30 |
DE69106425D1 (de) | 1995-02-16 |
HU210687B (en) | 1995-06-28 |
EP0453960A1 (de) | 1991-10-30 |
CA2040319C (en) | 1996-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI941378A (fi) | Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus | |
DE69418704T2 (de) | Anthranilsäure derivate | |
NO843836L (no) | Terapeutisk aktive sulfamatderivater | |
LU91210I2 (fr) | Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER) | |
DK0479546T3 (da) | Piperazinderivater | |
DK0640601T3 (da) | Benzamidderivat | |
ATE116650T1 (de) | Sulfonylamin substituierte bizyklische hydroxansäurederivate. | |
PT87277A (pt) | Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same | |
ES539123A0 (es) | Un compuesto de 3-indolcarboxamida | |
ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
ATE146481T1 (de) | Epoxysuccinamidsäurederivat | |
DE69527854T2 (de) | Derivate substituierter amidinonaphthylester | |
ATE47389T1 (de) | Kondensierte siebengliedrige heterozyklische verbindungen, ihre herstellung und verwendung. | |
DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
DE69007777D1 (de) | Derivate der p-Guanidinobenzoesäure zur Behandlung der zerebrovaskulären Kontraktion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |